New lens material may sharpen vision after cataract surgery

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients ≥ 18 years of age * Patients presenting for cataract surgery in routine clinical practice and eligible for multifocal IOL implantation (toric and non-toric) * Patients with grade 2/3 cataract density and comparable visual acuity in both eyes * Patient with a pregnancy test (negative pregnancy test), if applicable * Patient with signed consent to participate in the study * Patient affiliated to a social security scheme or entitled beneficiary Exclusion Criteria: * Children \< 18 years of age * Pregnancy or breast-feeding in progress or planned during the study. * History of anterior (cornea, anterior chamber, sulcus) or posterior (uveal, vitreoretinal) segment pathology, including retinal vascular occlusive disease, retinal detachment or peripheral retinal laser photocoagulation, AMD, glaucoma. * Any inflammation of the anterior or posterior segment, whatever the etiology, and/or history of any disease with intraocular inflammatory repercussions. * Clinically significant corneal pathology (epithelial, stromal and/or endothelial) that could have an impact on visual results. * Clinically significant moderate or severe dry eye that could affect study measurements. * History of intraocular or corneal surgery (refractive or trauma-related). * Presence or history of amblyopia or monofixation syndrome. * Subjects with conditions that increase the risk of zonular disruption during the phacoemulsification procedure that may affect the centration or postoperative orientation of the IOL. * Any other planned eye surgery, including, but not limited to, limbal relaxing incision (LRI)/astigmatic keratotomy and laser refractive surgery (LASIK). * Irregular astigmatism identified by corneal topography * Patients under guardianship, curatorship or safeguard of justice, as well as pregnant or breast-feeding women (article L1121-5 of the CSP).1.1 * Patient under AME